Endonovo Therapeutics Inc (OTCQB:ENDV.PK)

0.6501
Delayed Data
As of Jul 01
 0.00 / 0.00%
Today’s Change
0.51
Today|||52-Week Range
3.50
-47.99%
Year-to-Date
SECTOR
Finance
INDUSTRY
Finance/Rental/Leasing
MARKET CAP
$68.1M

Company Description

Endonovo Therapeutics, Inc. is a biotechnology company developing off the shelf regenerative products that no longer require the injection of stem cells. The company's first platform Cell Free Therapeutics harnesses the biological secretions of cells to create therapies that can be immediately administered following injuries or to treat acute and chronic diseases. Its second platform is the development of non invasive, bioelectronics to stimulate the body's natural repair system to treat injuries and inflammatory diseases. Endonovo Therapeutics was founded on May 26, 2011 and is headquartered in Woodland Hills, CA.

Contact Information

Endonovo Therapeutics, Inc.
6320 Canoga Avenue
Woodland Hills California 91367
P:(800) 701-1223
Investor Relations:
18007011223108

Employees

Shareholders

Individual stakeholders39.74%
Mutual fund holders--
Other institutional--

Top Executives

Alan Brian CollierChairman, CEO, CFO & Secretary
Michael Scott MannPresident & Executive VP-Shareholder Relations
Donald J. CalabriaChief Operating Officer
Randolph M. JohnsonExecutive Vice President-Clinical Development
Leonard MakowkaChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account